Rafael Coira, MD, JD and James Sherer, MD discuss the new FDA approval of the Esketamine nasal spray for treatment of depression. Marketed under the trade name Spravato, Esketamine promises to reverse depression in one day, but what are the risks of taking a medication derived from the drug PCP?